Exact Mass: 579.1349892000001

Exact Mass Matches: 579.1349892000001

Found 36 metabolites which its exact mass value is equals to given mass value 579.1349892000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Pelargonidin 3-rutinoside

5,7-dihydroxy-2-(4-hydroxyphenyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-1lambda4-chromen-1-ylium

C27H31O14+ (579.1713726)


Pelargonidin 3-rutinoside is a member of the class of compounds known as anthocyanidin-3-o-glycosides. Anthocyanidin-3-o-glycosides are phenolic compounds containing one anthocyanidin moiety which is O-glycosidically linked to a carbohydrate moiety at the C3-position. Pelargonidin 3-rutinoside is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Pelargonidin 3-rutinoside can be found in a number of food items such as gooseberry, lowbush blueberry, black chokeberry, and redcurrant, which makes pelargonidin 3-rutinoside a potential biomarker for the consumption of these food products.

   

Benanomicin C

7-Methoxypradimicinone II

C29H25NO12 (579.137669)


   

N-Acetyl-O-demethylpuromycin-5-phosphate

N-Acetyl-O-demethylpuromycin-5-phosphate

C23H30N7O9P (579.184254)


   

Pelargonidin 3-p-coumarylglucoside

5,7-dihydroxy-2-(4-hydroxyphenyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}methyl)oxan-2-yl]oxy}-1λ⁴-chromen-1-ylium

C30H27O12 (579.1502442000001)


Pelargonidin 3-p-coumarylglucoside is a member of the class of compounds known as anthocyanidin 3-o-6-p-coumaroyl glycosides. Anthocyanidin 3-o-6-p-coumaroyl glycosides are anthocyanidin 3-O-glycosides where the carbohydrate moiety is esterified at the C6 position with a p-coumaric acid. P-coumaric acid is an organic derivative of cinnamic acid, that carries a hydroxyl group at the 4-position of the benzene ring. Pelargonidin 3-p-coumarylglucoside is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Pelargonidin 3-p-coumarylglucoside can be found in common grape, which makes pelargonidin 3-p-coumarylglucoside a potential biomarker for the consumption of this food product.

   

Pelargonidin 3-rhamnoside 5-glucoside

7-hydroxy-2-(4-hydroxyphenyl)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-1λ⁴-chromen-1-ylium

C27H31O14+ (579.1713726)


Pelargonidin 3-rhamnoside 5-glucoside is found in common pea. Pelargonidin 3-rhamnoside 5-glucoside is isolated from Pisum species. Isolated from Pisum subspecies Pelargonidin 3-rhamnoside 5-glucoside is found in pulses and common pea.

   

Doxorubicin_hydrochloride

(8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride

C27H29NO11.HCl (579.15073)


Adriamycin hydrochloride appears as orange-red thin needles. Aqueous solutions yellow-orange at acid pHs, orange-red at neutral pHs, and violet blue over pH 9. (NTP, 1992) Doxorubicin hydrochloride is an anthracycline. ["Doxorubicin hydrochloride (liposomal) is an antineoplastic prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of certain types of cancer, including ovarian cancer, multiple myeloma, and AIDS-related Kaposi sarcoma.","Kaposi sarcoma is caused by infection with human herpesvirus-8 (HHV-8). HHV-8 infection can be an opportunistic infection (OI) of HIV."] Doxorubicin Hydrochloride is the hydrochloride salt of doxorubicin, an anthracycline antibiotic with antineoplastic activity. Doxorubicin, isolated from the bacterium Streptomyces peucetius var. caesius, is the hydroxylated congener of daunorubicin. Doxorubicin intercalates between base pairs in the DNA helix, thereby preventing DNA replication and ultimately inhibiting protein synthesis. Additionally, doxorubicin inhibits topoisomerase II which results in an increased and stabilized cleavable enzyme-DNA linked complex during DNA replication and subsequently prevents the ligation of the nucleotide strand after double-strand breakage. Doxorubicin also forms oxygen free radicals resulting in cytotoxicity secondary to lipid peroxidation of cell membrane lipids; the formation of oxygen free radicals also contributes to the toxicity of the anthracycline antibiotics, namely the cardiac and cutaneous vascular effects. Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. See also: Doxorubicin (has active moiety). C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors Doxorubicin (Hydroxydaunorubicin) hydrochloride, a cytotoxic anthracycline antibiotic, is an anti-cancer chemotherapy agent. Doxorubicin hydrochloride is a potent human DNA topoisomerase I and topoisomerase II inhibitor with IC50s of 0.8 μM and 2.67 μM, respectively. Doxorubicin hydrochloride reduces basal phosphorylation of AMPK and its downstream target acetyl-CoA carboxylase. Doxorubicin hydrochloride induces apoptosis and autophagy[1][2][3]. Doxorubicin (Hydroxydaunorubicin) hydrochloride, a cytotoxic anthracycline antibiotic, is an anti-cancer chemotherapy agent. Doxorubicin hydrochloride is a potent human DNA topoisomerase I and topoisomerase II inhibitor with IC50s of 0.8 μM and 2.67 μM, respectively. Doxorubicin hydrochloride reduces basal phosphorylation of AMPK and its downstream target acetyl-CoA carboxylase. Doxorubicin hydrochloride induces apoptosis and autophagy[1][2][3]. Doxorubicin (Hydroxydaunorubicin) hydrochloride, a cytotoxic anthracycline antibiotic, is an anti-cancer chemotherapy agent. Doxorubicin hydrochloride is a potent human DNA topoisomerase I and topoisomerase II inhibitor with IC50s of 0.8 μM and 2.67 μM, respectively. Doxorubicin hydrochloride reduces basal phosphorylation of AMPK and its downstream target acetyl-CoA carboxylase. Doxorubicin hydrochloride induces apoptosis and autophagy[1][2][3].

   

Pelargonidin 3-robinobioside

Pelargonidin 3-robinobioside

C27H31O14 (579.1713726)


   

Apigeninidin 5,7-diglucoside

Apigeninidin 5,7-diglucoside

C27H31O14 (579.1713726)


   

Pelargonidin 3-neohesperidoside

3,5,7,4-Tetrahydroxyflavylium 3-rhamnosyl- (1->2) -glucoside

C27H31O14 (579.1713726)


   

Malvidin 3-(6-malonylglucoside)

Malvidin 3-(6-malonylglucoside)

C26H27O15 (579.1349892000001)


   

Pelargonidin 3-p-coumarylglucoside

Pelargonidin 3-(6-p-coumaroyl)glucoside

C30H27O12+ (579.1502442000001)


   

Pelargonidin 3-rutinoside

Pelargonidin 3-rutinoside

C27H31O14 (579.1713726)


   
   

(6R)-7t-((R)-5-amino-5-carboxy-pentanoylamino)-3-[3-(4-hydroxy-phenyl)-2-methoxy-acryloyloxymethyl]-7c-methoxy-8-oxo-(6rH)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cephamycin B|cephamycin-B

(6R)-7t-((R)-5-amino-5-carboxy-pentanoylamino)-3-[3-(4-hydroxy-phenyl)-2-methoxy-acryloyloxymethyl]-7c-methoxy-8-oxo-(6rH)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid|Cephamycin B|cephamycin-B

C25H29N3O11S (579.1522724)


   
   

Pelargonidin 3-O-rutinoside

Pelargonidin 3-O-rutinoside

[C27H31O14]+ (579.1713726)


   

Pelargonidin 3-rhamnoside 5-glucoside

7-hydroxy-2-(4-hydroxyphenyl)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-1$l^{4}-chromen-1-ylium

C27H31O14 (579.1713726)


   

Pelargonidin 3-rhamnoside-5-glucoside

Pelargonidin 3-rhamnoside-5-glucoside

C27H31O14 (579.1713726)


   

Chloro[(1,3-dimesitylimidazol-2-ylidene)(N,N-dimethylbenzylamine)palladium(II)]

Chloro[(1,3-dimesitylimidazol-2-ylidene)(N,N-dimethylbenzylamine)palladium(II)]

C30H36ClN3Pd (579.1632356)


   

Epirubicin hydrochloride

Epirubicin hydrochloride

C27H30ClNO11 (579.1507300000001)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors

   

Oxyvanadium phthalocyanine

Oxyvanadium phthalocyanine

C32H16N8OV (579.0886636)


   
   

Danicopan

Danicopan

C26H23BrFN7O3 (579.1029679999999)


COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C308 - Immunotherapeutic Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Mezlocillin Sodium Monohydrate

Mezlocillin Sodium Monohydrate

C21H26N5NaO9S2 (579.1069586000001)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

Guadecitabine sodium

Guadecitabine sodium

C18H23N9NaO10P (579.1203148)


C471 - Enzyme Inhibitor > C2083 - DNA Methyltransferase Inhibitor C274 - Antineoplastic Agent > C132686 - Demethylating Agent D000970 - Antineoplastic Agents

   

Doxorubicin Hydrochloride

Doxorubicin Hydrochloride

C27H30ClNO11 (579.1507300000001)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors Doxorubicin (Hydroxydaunorubicin) hydrochloride, a cytotoxic anthracycline antibiotic, is an anti-cancer chemotherapy agent. Doxorubicin hydrochloride is a potent human DNA topoisomerase I and topoisomerase II inhibitor with IC50s of 0.8 μM and 2.67 μM, respectively. Doxorubicin hydrochloride reduces basal phosphorylation of AMPK and its downstream target acetyl-CoA carboxylase. Doxorubicin hydrochloride induces apoptosis and autophagy[1][2][3]. Doxorubicin (Hydroxydaunorubicin) hydrochloride, a cytotoxic anthracycline antibiotic, is an anti-cancer chemotherapy agent. Doxorubicin hydrochloride is a potent human DNA topoisomerase I and topoisomerase II inhibitor with IC50s of 0.8 μM and 2.67 μM, respectively. Doxorubicin hydrochloride reduces basal phosphorylation of AMPK and its downstream target acetyl-CoA carboxylase. Doxorubicin hydrochloride induces apoptosis and autophagy[1][2][3]. Doxorubicin (Hydroxydaunorubicin) hydrochloride, a cytotoxic anthracycline antibiotic, is an anti-cancer chemotherapy agent. Doxorubicin hydrochloride is a potent human DNA topoisomerase I and topoisomerase II inhibitor with IC50s of 0.8 μM and 2.67 μM, respectively. Doxorubicin hydrochloride reduces basal phosphorylation of AMPK and its downstream target acetyl-CoA carboxylase. Doxorubicin hydrochloride induces apoptosis and autophagy[1][2][3].

   
   

[2-[Carboxymethyl-[2-[carboxymethyl-[2-[carboxymethyl-[2-(methylamino)-2-oxoniumylideneethyl]amino]ethyl]amino]ethyl]amino]-1-(methylamino)ethylidene]oxidanium;gadolinium(2+)

[2-[Carboxymethyl-[2-[carboxymethyl-[2-[carboxymethyl-[2-(methylamino)-2-oxoniumylideneethyl]amino]ethyl]amino]ethyl]amino]-1-(methylamino)ethylidene]oxidanium;gadolinium(2+)

C16H31GdN5O8+4 (579.1413636)


V - Various > V08 - Contrast media > V08C - Magnetic resonance imaging contrast media > V08CA - Paramagnetic contrast media

   

cyanidin 3-O-[beta-D-xylosyl-(1->2)-beta-D-galactoside](1-)

cyanidin 3-O-[beta-D-xylosyl-(1->2)-beta-D-galactoside](1-)

C26H27O15- (579.1349892000001)


   

2-{benzyl[(4-methylphenyl)sulfonyl]amino}-N-(2-{[(2-furylmethyl)amino]carbonyl}phenyl)benzamide

2-{benzyl[(4-methylphenyl)sulfonyl]amino}-N-(2-{[(2-furylmethyl)amino]carbonyl}phenyl)benzamide

C33H29N3O5S (579.1827824000001)


   

5-methyluridine 5-[3-(alpha-D-glucopyranosyl) dihydrogen diphosphate]

5-methyluridine 5-[3-(alpha-D-glucopyranosyl) dihydrogen diphosphate]

C16H27N3O16P2 (579.0866522)


   

(2S,3S,4S,5R)-6-[2-[2-[7-chloro-5-(2-fluorophenyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]ethyl-ethylamino]ethoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

(2S,3S,4S,5R)-6-[2-[2-[7-chloro-5-(2-fluorophenyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]ethyl-ethylamino]ethoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C27H31ClFN3O8 (579.1783608000001)


   

7-Methoxypradimicinone II

7-Methoxypradimicinone II

C29H25NO12 (579.137669)


   

Pelargonidin 3-(6-p-coumaroyl)glucoside

Pelargonidin 3-(6-p-coumaroyl)glucoside

C30H27O12+ (579.1502442000001)


An anthocyanidin glycoside that is the cinnamate ester obtained by the formal condensation of 6-hydroxy group of pelargonidin 3-O-beta-D-glucoside with trans-4-coumaric acid.

   

Pelargonidin 3-O-rutinoside

Pelargonidin 3-O-rutinoside

C27H31O14+ (579.1713726)


An anthocyanin cation consisting of pelargonidin having a rutinosyl [6-deoxy-alpha-L-mannosyl-(1->6)-beta-D-glucosyl] residue attached at the 3-hydroxy position.

   

Malvidin 3-(malonyl)glucoside

Malvidin 3-(6'-malonylglucoside)

C26H27O15 (579.1349892000001)